Loree Easley, PA
Physician Assistant · Bartlett, TNNPI 1417108259
Payments from drug & device makers
Across 1,315 payments — averaging $158.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$44K
- UCB, Inc.$34K
- AbbVie$27K
- Galderma Laboratories, L.p.$26K
- Regeneron$22K
- Janssen Scientific Affairs, LLC$19K
- plus $36K from 27 others
What the payments were for
- Consulting fees$16,1779%
- Speaking & faculty fees$131,94771%
- Travel & lodging$15,5258%
- Food & beverage$22,18312%
- Education$7260%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 166 | $43,780 |
| UCB, Inc. | 106 | $34,328 |
| AbbVie | 274 | $27,317 |
| Galderma Laboratories, L.p. | 77 | $26,158 |
| Regeneron | 7 | $22,343 |
| Janssen Scientific Affairs, LLC | 22 | $18,710 |
| Sun Pharmaceutical Industries Inc. | 43 | $11,400 |
| E.r. Squibb & Sons, L.L.C. | 62 | $6,629 |
| Arcutis Biotherapeutics, Inc. | 36 | $5,285 |
| Novartis | 61 | $4,107 |
| LEO Pharma Inc. | 44 | $2,126 |
| Incyte Corporation | 73 | $1,099 |
| Pfizer | 70 | $752 |
| Medimetriks Pharmaceuticals, Inc. | 65 | $608 |
| Sanofi | 30 | $602 |
| Journey Medical Corporation | 3 | $517 |
| Amgen | 31 | $514 |
| Lilly USA, LLC | 31 | $501 |
| Regeneron Healthcare Solutions, Inc. | 21 | $497 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $430 |
| Dermavant Sciences, Inc. | 20 | $286 |
| Boehringer Ingelheim | 9 | $194 |
| Almirall LLC | 8 | $160 |
| VYNE Pharmaceuticals Inc. | 8 | $145 |
| Organon | 9 | $105 |
| Organogenesis Inc. | 4 | $94 |
| Mayne Pharma Commercial LLC | 3 | $61 |
| Botanix SB Inc | 3 | $53 |
| Sanofi-aventis U.S. LLC | 1 | $30 |
| Sandoz | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Biofrontera Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$208,900 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 24 | $483,584 |
| StelaraUstekinumab | 11 | $195,330 |
| Dupixent SyringeDupilumab | 24 | $86,389 |
| Clobetasol Propionate | 48 | $3,144 |
| Metronidazole | 19 | $1,475 |
| Doxycycline Hyclate | 63 | $1,292 |
| Ketoconazole | 70 | $1,085 |
| Triamcinolone Acetonide | 55 | $916 |
| Nystatin | 42 | $788 |
| ValacyclovirValacyclovir Hcl | 20 | $491 |
| Betamethasone Dipropionate | 11 | $459 |
| Minoxidil | 24 | $389 |
| Clotrimazole | 13 | $319 |
| Mometasone Furoate | 18 | $258 |
| NystopNystatin | 11 | $240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $43,780 | $195,33011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Bartlett
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
- Nicholas BarkemeyerNashville$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.